http://denver.yourhub.comThe latest story posts in The Denver Newspaper Agency YourHub.comen-usnews@yourhub.com(c) 2009, YourHub.com5Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Denver/Stories/Archive/Health-Fitness/Resources/Story~358290.aspx9/6/2007 1:27:05 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Parker/Stories/Archive/Health-Fitness/Resources/Story~358307.aspx9/6/2007 1:44:44 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Aurora/Stories/Archive/Health-Fitness/Resources/Story~358313.aspx9/6/2007 1:51:40 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Aurora/Stories/Archive/Health-Fitness/Resources/Story~358316.aspx9/6/2007 1:53:39 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Boulder/Stories/Archive/Health-Fitness/Resources/Story~358317.aspx9/6/2007 1:56:10 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Brighton/Stories/Archive/Health-Fitness/Resources/Story~358321.aspx9/6/2007 2:05:08 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/CastleRock/Stories/Archive/Health-Fitness/Resources/Story~358325.aspx9/6/2007 2:09:51 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Englewood/Stories/Archive/Health-Fitness/Resources/Story~358329.aspx9/6/2007 2:13:35 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/HighlandsRanch/Stories/Archive/Health-Fitness/Resources/Story~358330.aspx9/6/2007 2:16:07 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Littleton/Stories/Archive/Health-Fitness/Resources/Story~358332.aspx9/6/2007 2:17:39 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Longmont/Stories/Archive/Health-Fitness/Resources/Story~358335.aspx9/6/2007 2:20:06 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Westminster/Stories/Archive/Health-Fitness/Resources/Story~358340.aspx9/6/2007 2:22:27 PMspencer green Benign prostatic hypertrophy or (BPH) is the gradual enlargement of the prostate which occurs in most men as they age. This seems to be a natural process and is very common affecting over 10 million American men; half of all men over the age of 50 and nearly 80% of men over the age of 70. ...http://denver.yourhub.com/Thornton/Stories/Archive/Health-Fitness/Resources/Story~358342.aspx9/6/2007 2:24:45 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Arvada/Stories/News/General-News/Story~510081.aspx8/19/2008 11:22:58 AMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Boulder/Stories/News/General-News/Story~510099.aspx8/19/2008 11:55:08 AMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Brighton/Stories/News/General-News/Story~510101.aspx8/19/2008 11:57:55 AMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Broomfield/Stories/News/General-News/Story~510104.aspx8/19/2008 12:00:34 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/CastlePines/Stories/News/General-News/Story~510107.aspx8/19/2008 12:04:09 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/CastleRock/Stories/News/General-News/Story~510111.aspx8/19/2008 12:13:17 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM, by Veridex LLC. ...http://denver.yourhub.com/Centennial/Stories/News/General-News/Story~510112.aspx8/19/2008 12:15:30 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/CherryHillsVillage/Stories/News/General-News/Story~510114.aspx8/19/2008 12:17:44 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/CommerceCity/Stories/News/General-News/Story~510115.aspx8/19/2008 12:20:01 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Conifer/Stories/News/General-News/Story~510116.aspx8/19/2008 12:22:05 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Denver/Stories/News/General-News/Story~510117.aspx8/19/2008 12:25:28 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/DenverNorth/Stories/News/General-News/Story~510119.aspx8/19/2008 12:27:34 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM, by Veridex LLC. W...http://denver.yourhub.com/DenverSouth/Stories/News/General-News/Story~510122.aspx8/19/2008 12:29:34 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Edgewater/Stories/News/General-News/Story~510123.aspx8/19/2008 12:31:33 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Englewood/Stories/News/General-News/Story~510125.aspx8/19/2008 12:33:40 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Erie/Stories/News/General-News/Story~510131.aspx8/19/2008 12:40:08 PMspencer green The University of Colorado Denver's Department of Pathology at the Anschutz Medical Campus has recently acquired a technology for tracking Circulating Tumor Cells (CTC) in patients with metastatic breast, colorectal and prostate cancer. The technology is called CellSearch TM , by Veridex ...http://denver.yourhub.com/Evergreen/Stories/News/General-News/Story~510133.aspx8/19/2008 12:42:33 PMspencer green